Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 20, 2005. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transaction notifications rather than financial performance results.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details specific share movements within the SmithKline Beecham Employee Benefit Trust ("the Trust") on July 4 and July 15, 2005:
- July 4, 2005: 13,446 Ordinary shares were transferred from the Trust to a participant in the GlaxoSmithKline Annual Investment Plan.
- July 15, 2005: 707 Ordinary shares were purchased for the SmithKline Beecham Bonus Investment Plan at a price of £13.73 per share following dividend reinvestment.
- July 15, 2005: 7,751 Ordinary shares were purchased for the GlaxoSmithKline Annual Investment Plan at a price of £13.73 per share following dividend reinvestment.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It notes that Director Julian Heslop holds an interest in the shares held in the Trust in the same capacity as other non-US employees or former employees. The transactions were notified in accordance with Disclosure rule 3.1.4R(1)(b).
Investor Verification Checklist
- Verify the total number of shares held by the SmithKline Beecham Employee Benefit Trust following these transactions.
- Confirm the impact of the £13.73 share price on the valuation of the Trust's holdings.
- Review the full Disclosure rule 3.1.4R(1)(b) requirements to ensure compliance with the reported transactions.
- Check subsequent filings for any further changes in director interests or Trust activities.